Related Experiment Video
Updated: Jan 24, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Pediatric Hypereosinophilia: Characteristics, Clinical Manifestations, and Diagnoses
Dara Burris1, Chen E Rosenberg1, Justin T Schwartz1
1Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Insights
Pediatric hypereosinophilia is common, affecting 54.4 per 100,000 children annually. Secondary causes like atopic dermatitis and infections are most frequent, necessitating thorough clinical evaluation.
Area of Science:
- Pediatric Hematology
- Immunology
- Clinical Diagnostics
Background:
- Eosinophilia presents a broad differential diagnosis, encompassing allergic, infectious, and neoplastic conditions.
- Limited data exists on hypereosinophilia specifically within pediatric populations.
- Understanding pediatric hypereosinophilia is crucial for accurate diagnosis and management.
Purpose of the Study:
- To identify pediatric hypereosinophilia cases at a tertiary center.
- To characterize clinical features and associated diseases.
- To estimate the incidence of pediatric hypereosinophilia.
Main Methods:
- Retrospective chart review of patients under 18 with elevated absolute eosinophil counts (AECs) on multiple occasions.
- Data collected included clinical characteristics, laboratory values, and diagnoses.
- Study period: January 1, 2008, to May 31, 2017.
Main Results:
- Secondary hypereosinophilia was the most common cause.
- Atopic dermatitis, graft-versus-host disease, sickle cell disease, and parasitic infections were frequent associations.
- Incidence was 54.4 per 100,000 persons/year, with peak occurrences in children aged 6-11 and under 1 year.
Conclusions:
- Pediatric hypereosinophilia is underrecognized despite its incidence.
- Secondary causes are prevalent, requiring comprehensive diagnostic workups.
- Clinicians should maintain a high index of suspicion and pursue thorough evaluations for pediatric hypereosinophilia.
Background:
Eosinophilia is associated with various conditions, including allergic, infectious, and neoplastic disorders. The diagnostic differential is broad, and data on hypereosinophilia in pediatric patients are limited.
Objective:
The objectives of this study were to identify cases of hypereosinophilia in a tertiary pediatric medical center, determine clinical characteristics and disease associations, and estimate the incidence of hypereosinophilia in the hospital and geographic populations.
Methods:
A retrospective chart review included patients younger than 18 years presenting to a tertiary pediatric medical center (January 1, 2008, to May 31, 2017) with absolute eosinophil counts (AECs) greater than or equal to 1.50 thousand eosinophils/microliter (K/μL) recorded on at least 2 occasions at least 4 weeks apart (N = 176). Clinical characteristics, laboratory values, treatment course, and associated diagnoses were evaluated.
Results:
The most common cause of hypereosinophilia in this cohort was secondary hypereosinophilia. Atopic dermatitis, graft-versus-host disease, sickle cell disease, and parasitic infections were the most common conditions associated with hypereosinophilia. Median age at diagnosis was 4.6 (interquartile range, 1.5-10.5) years. Median peak AEC was 3.16 (2.46-4.78) K/μL. Hypereosinophilia occurred most frequently in patients aged between 6 and 11 years (24.4%) and younger than 1 year (18.2%). Patients with neoplasms and immune deficiencies had significantly higher peak AECs than did patients with overlap hypereosinophilic syndrome and atopic diseases (P < .0001).
Conclusions:
Pediatric hypereosinophilia has an incidence of 54.4 per 100,000 persons per year, with children younger than 1 year and aged 6 to 11 years accounting for most affected patients. Pediatric hypereosinophilia is not uncommon and remains underrecognized, highlighting a need for clinicians to identify patients who meet criteria for hypereosinophilia and to pursue a thorough evaluation.
Related Concept Videos
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Heart Failure III: Clinical Manifestations
Acute Pancreatitis II: Clinical Manifestations and Management
Angina III: Clinical Manifestations and Assessment

